<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Ebstein anomaly: Clinical manifestations and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Ebstein anomaly: Clinical manifestations and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Ebstein anomaly: Clinical manifestations and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Heidi M Connolly, MD, FACC, FASE</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Muhammad Yasir Qureshi, MBBS, FACC, FASE</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Matthias Greutmann, MD, FESC</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David R Fulton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 15, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Ebstein anomaly is a congenital malformation that is characterized primarily by abnormalities of the tricuspid valve and right ventricle  (<a class="graphic graphic_figure graphicRef103702" href="/d/graphic/103702.html" rel="external">figure 1</a>). The clinical presentation of Ebstein anomaly varies widely, ranging from the critically ill fetus to the asymptomatic adult, depending upon the degree of anatomic abnormality. The clinical manifestations and diagnosis of Ebstein anomaly are discussed here.</p><p>The management and prognosis of Ebstein anomaly are discussed separately. (See  <a class="medical medical_review" href="/d/html/108790.html" rel="external">"Ebstein anomaly: Management and prognosis"</a>.)</p><p class="headingAnchor" id="H520904259"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The incidence of Ebstein anomaly in the general population has been estimated to be 1.2 to 5 in 100,000 live births with no predilection for either gender [<a href="#rid1">1-4</a>]. The genetic predisposition for Ebstein anomaly is considered heterogeneous [<a href="#rid5">5-8</a>]. The risk of Ebstein anomaly in infants of mothers taking <a class="drug drug_general" data-topicid="9566" href="/d/drug information/9566.html" rel="external">lithium</a> during early pregnancy is discussed separately. (See  <a class="medical medical_review" href="/d/html/17159.html" rel="external">"Teratogenicity, pregnancy complications, and postnatal risks of antipsychotics, benzodiazepines, lithium, and electroconvulsive therapy", section on 'Lithium'</a>.)</p><p class="headingAnchor" id="H10180283"><span class="h1">MORPHOLOGY</span></p><p class="headingAnchor" id="H2"><span class="h2">Tricuspid valve</span><span class="headingEndMark"> — </span>The morphology of the tricuspid valve in Ebstein anomaly, and consequently the clinical presentation, is highly variable. The tricuspid valve leaflets demonstrate variable degrees of failed delamination (separation of the valve tissue from the myocardium) with fibrous and muscular attachments to the right ventricular myocardium  (<a class="graphic graphic_diagnosticimage graphicRef103911" href="/d/graphic/103911.html" rel="external">image 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>The displacement of hinge points of septal and posterior (inferior) leaflets into the right ventricle toward the apex and right ventricular outflow tract is the hallmark finding of Ebstein anomaly.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The posterior (inferior) and septal tricuspid valve leaflets are generally most severely affected, related to the failure of delamination from the myocardium. The tricuspid valve functional orifice is generally displaced anteriorly and downward from the atrioventricular junction toward the right ventricular apex, and sometimes superiorly toward the right ventricular outflow tract along the direction of blood flow (rotation of the tricuspid functional orifice along the inner curvature of the right ventricle).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The anterior leaflet is the largest leaflet and is usually attached to the anatomic tricuspid valve annulus at the atrioventricular junction, with variable tethering to the right ventricular endocardium; this leaflet is often referred to as being "sail-like."</p><p></p><p>The free edges of the leaflets of the tricuspid valve may attach to chordae or directly to the papillary muscle(s) or the underlying myocardium.</p><p>In Ebstein anomaly, the tricuspid valve typically shows variable degrees of regurgitation; a severe degree of regurgitation is common. Tissue defects within the leaflets of the tricuspid valve ("fenestrations") may contribute to the regurgitation. Tricuspid valve stenosis is rare in Ebstein anomaly.</p><p class="headingAnchor" id="H3"><span class="h2">Right ventricle</span><span class="headingEndMark"> — </span>The displacement of the valve divides the right ventricle into two chambers:</p><p class="bulletIndent1"><span class="glyph">●</span>The proximal portion is called "atrialized right ventricle" because of a downward displacement of the tricuspid valve and functional orifice.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The distal chamber, the functional right ventricle, is of variable size [<a href="#rid9">9</a>]. This portion of the right ventricle may appear small on the echocardiographic apical four-chamber view but often still appears enlarged by cardiovascular magnetic resonance (CMR) imaging [<a href="#rid9">9</a>]. In some severe cases, the functional right ventricle consists of only the right ventricular outflow tract and may not be visible from the apical four-chamber view on echocardiography.</p><p></p><p>Due to the underlying myocardial abnormalities, right ventricular performance is almost always abnormal. The atrialized right ventricle is usually thin-walled and demonstrates poor contractility. Furthermore, right ventricular ejection fraction may overestimate true right ventricular contractility in the setting of severe tricuspid regurgitation.</p><p class="headingAnchor" id="H977796647"><span class="h2">Associated cardiovascular defects</span><span class="headingEndMark"> — </span>Ebstein anomaly is commonly associated with one or more congenital cardiac malformations in addition to the tricuspid valve and right ventricular findings. </p><p>The following findings are the most common [<a href="#rid10">10-13</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Patent foramen ovale (PFO) or atrial septal defect (ASD); most commonly secundum ASD. Interatrial communication is commonly identified in patients with Ebstein anomaly. Patients with PFO or ASD can develop cyanosis from right to left shunting, particularly with exercise, and are at risk of paradoxical embolism. (See  <a class="medical medical_review" href="/d/html/1420.html" rel="external">"Patent foramen ovale"</a> and  <a class="medical medical_review" href="/d/html/1418.html" rel="external">"Clinical manifestations and diagnosis of atrial septal defects in adults"</a>.)</p><p></p><p class="bulletIndent1">In one series, 79 percent of patients had either a persistent or previously closed PFO or atrial septal defect [<a href="#rid11">11</a>]. In contrast, in a registry study including 530 patients with Ebstein anomaly from Denmark and Sweden, concomitant atrial septal defect only was identified in 10.7 percent, and other congenital cardiac disease was identified in 42.5 percent [<a href="#rid4">4</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ventricular septal defect. (See  <a class="medical medical_review" href="/d/html/5787.html" rel="external">"Isolated ventricular septal defects (VSDs) in infants and children: Anatomy, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary outflow tract obstruction is rare and may be due to anatomic or functional pulmonary atresia, structural pulmonic valve stenosis, or occasionally the displaced tricuspid valve. (See  <a class="medical medical_review" href="/d/html/8120.html" rel="external">"Clinical manifestations and diagnosis of pulmonic stenosis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patent ductus arteriosus. (See  <a class="medical medical_review" href="/d/html/1421.html" rel="external">"Clinical manifestations and diagnosis of patent ductus arteriosus (PDA) in term infants, children, and adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Accessory conduction pathway(s) are present in 6 to 36 percent of patients with Ebstein anomaly [<a href="#rid14">14</a>], predisposing patients to arrhythmias. Syncope and sudden death have been reported and may be caused by atrial fibrillation with a rapid ventricular response due to fast conduction through an accessory pathway or from ventricular arrhythmias. Arrhythmias may also occasionally precipitate heart failure. (See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis", section on 'Associated cardiac abnormalities'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Left heart lesions are occasionally identified in Ebstein anomaly, including left ventricular systolic and diastolic dysfunction, mitral valve prolapse, bicuspid aortic valve, myocardial changes resembling left ventricular noncompaction, and, rarely, left ventricular outflow tract obstruction [<a href="#rid11">11</a>]. The left ventricle may be small in patients with Ebstein anomaly due to severe tricuspid valve regurgitation, or it may appear small by imaging due to marked right heart involvement.</p><p></p><p class="headingAnchor" id="H6"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H7"><span class="h2">Clinical presentation</span><span class="headingEndMark"> — </span>The clinical presentation of Ebstein anomaly varies widely depending upon the extent of tricuspid valve disease, the severity of right ventricular dysfunction, the direction of the shunt across the atrial septum, and any associated congenital cardiac lesions. </p><p>The age of diagnosis of Ebstein anomaly has markedly declined since the 1970s, as illustrated by the above cited registry study in which the median age of diagnosis declined from 26.9 years during 1970 to 1979 to 4.8 months during 2000 to 2017, likely reflecting improved diagnostic modalities [<a href="#rid4">4</a>]. </p><p>In general, symptoms are related to the degree of anatomic abnormality (ie, the degree of displacement and the functional status of the tricuspid valve leaflets, presence of inter-atrial communication, and severity of right ventricular dilation and dysfunction). The wide spectrum of disease is illustrated by the following clinical presentations:</p><p class="bulletIndent1"><span class="glyph">●</span>The anomaly may be fatal in utero or shortly after birth if severe cardiomegaly, pulmonary hypoplasia due to massive cardiomegaly, and heart failure are present [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children and adults with marked tricuspid leaflet displacement may have severe regurgitation, right-sided heart failure, elevated right atrial pressures, and significant cyanosis due to right-to-left interatrial shunting with or without functional/anatomic pulmonary valve atresia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In contrast, patients with milder apical displacement and milder dysfunction of the tricuspid valve (mild to moderate tricuspid regurgitation) may remain asymptomatic through adulthood or present in adulthood with arrhythmia or paradoxical embolic event [<a href="#rid16">16</a>].</p><p></p><p>In a review of 220 patients with Ebstein anomaly presenting between 1958 and 1991, early age at presentation was frequently associated with other cardiac lesions, particularly atrial septal defect and pulmonary stenosis, which predisposes to cyanosis from right-to-left shunting [<a href="#rid15">15</a>]. The clinical presentation varied with age at diagnosis:</p><p class="bulletIndent1"><span class="glyph">●</span>Fetuses – An abnormal routine prenatal scan (86 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Neonates – Cyanosis (74 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Infants – Heart failure (43 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Children – Murmur (63 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Adolescents and adults – Arrhythmia (42 percent)</p><p></p><p>Symptomatic neonates with severe cyanosis, severe cardiomegaly, and respiratory distress require intense medical management. Circular shunt and fetal hydrops are markers of the worst prognosis, as there are limited surgical options. A circular shunt can develop in utero, or after birth if pulmonary valve regurgitation and patent ductus arteriosus are present; this is a result of blood flowing from left ventricle to aorta to pulmonary artery (through ductus arteriosus) and then retrograde through the pulmonary valve, right ventricle, and tricuspid valve, across the atrial septum and back into the left ventricle and aorta. This circular shunt adds significant volume load to the ventricles in the presence of hypoxemia, leading to severe congestive heart failure in neonates and hydrops in fetuses with Ebstein anomaly.</p><p>In infants with severe tricuspid regurgitation, dyspnea, heart failure, and cyanosis from shunting across an atrial septal defect may be present soon after birth, because of high pulmonary vascular resistance [<a href="#rid15">15</a>]. These symptoms and signs often improve as pulmonary vascular resistance decreases. However, in cases with mechanical obstruction to right ventricular outflow related to pulmonary atresia, small pulmonary arteries, pulmonary valve stenosis, or a noncompliant small right ventricle, improvement may not occur or be limited.</p><p>In children, adolescents, and adults, symptoms such as exertional dyspnea, fatigue, cyanosis, transient ischemic attack/stroke, and palpitations may occur; these symptoms may be due to right ventricular dysfunction, severe tricuspid valve regurgitation, or right-to-left shunt at the atrial level. Atrial tachyarrhythmias are present in approximately 20 to 30 percent of cases across age groups, with greater frequency in adolescents and adults [<a href="#rid15">15,17</a>]. Some of these arrhythmias may be due to accessory conduction pathway(s), present in up to 20 percent of patients; the majority of these pathways are located around the orifice of the malformed tricuspid valve [<a href="#rid11">11,18,19</a>]. Patients with Ebstein anomaly who have an interatrial communication are at risk for paradoxical embolization and may develop symptoms of cyanosis, stroke, transient ischemic attack, or brain abscess [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H3427294775"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>Physical findings vary with the severity of pathology and the magnitude of right-to-left interatrial shunting [<a href="#rid15">15</a>]. The following observations apply to patients with more severe disease (usually neonates and children); those with less severe disease usually present with a murmur and click commonly mistaken for mitral valve prolapse.</p><p>Cyanosis may be severe in infants. Common findings in older children include mild cyanosis, prominent "a" wave in the distended jugular veins, and hepatomegaly. The last finding represents passive hepatic congestion resulting from tricuspid regurgitation and elevated right atrial pressure. There may also be a palpable prominent diffuse parasternal impulse and occasionally a systolic thrill is noted at the left lower sternal border. (See  <a class="medical medical_review" href="/d/html/1076.html" rel="external">"Examination of the jugular venous pulse"</a> and  <a class="medical medical_review" href="/d/html/1081.html" rel="external">"Examination of the precordial pulsation"</a>.)</p><p>On auscultation, first and second heart sounds are widely split due to the right bundle branch block; an early systolic click or "sail sound" may also be heard [<a href="#rid21">21</a>]. A prominent S3 and/or a loud S4 give the impression of multiple heart sounds (triple or quadruple gallop). A systolic murmur from tricuspid regurgitation is a common finding; this murmur characteristically increases in intensity with inspiration and may be associated with a mid-diastolic murmur due to the high diastolic flow volume across the tricuspid annulus. (See  <a class="medical medical_review" href="/d/html/1078.html" rel="external">"Auscultation of cardiac murmurs in adults"</a>.)</p><p>However, the murmur may be very soft or absent in adults because the low velocity of the to-and-fro flow and rapid equalization of pressure across the tricuspid valve do not result in blood flow turbulence. When tricuspid regurgitation is severe, jugular venous distension and a prominent "v" wave is occasionally seen; the "v" wave is often absent in Ebstein anomaly due to a large and compliant right atrium and atrialized right ventricle that absorbs the tricuspid regurgitation. For the same reason, the liver may not be pulsatile even in the setting of severe tricuspid valve regurgitation.</p><p class="headingAnchor" id="H4165414602"><span class="h2">Initial test results</span><span class="headingEndMark"> — </span>An electrocardiogram (ECG) and a chest radiograph are common tests obtained in the initial evaluation of cardiac patients. Further testing for diagnosis and evaluation of Ebstein anomaly (including echocardiography which is a key test) is discussed below. (See <a class="local">'Approach to diagnosis and evaluation'</a> below.)</p><p class="headingAnchor" id="H3844343682"><span class="h3">Electrocardiogram</span><span class="headingEndMark"> — </span>An ECG is not required for the diagnosis of Ebstein anomaly but is an important component of the overall evaluation of patients with this condition to detect arrhythmias and evidence of preexcitation [<a href="#rid22">22</a>]. The ECG usually reveals abnormal findings in Ebstein anomaly. These include  (<a class="graphic graphic_waveform graphicRef109939" href="/d/graphic/109939.html" rel="external">waveform 1B</a>) [<a href="#rid14">14,23</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Right atrial enlargement with characteristic "Himalayan P waves" and right bundle branch block.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Preexcitation with a left bundle branch pattern with predominant S waves in the right precordium due to right-sided accessory pathway  (<a class="graphic graphic_waveform graphicRef80258 graphicRef109939" href="/d/graphic/80258.html" rel="external">waveform 1A-B</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Preexcitation can sometimes be subtle. Right ventricular preexcitation may manifest as a lack of right bundle branch block with a short PR interval.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Low-voltage QRS over the right-sided chest leads.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Supraventricular tachycardia may be present with or without preexcitation; other forms of atrial tachycardia, such as ectopic atrial tachycardia, atrial flutter, or atrial fibrillation, may be seen in older persons.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>PR interval prolongation may also be seen; this is primarily due to intra-atrial conduction delay rather than atrioventricular nodal dysfunction.</p><p></p><p class="headingAnchor" id="H3413257793"><span class="h3">Chest radiograph</span><span class="headingEndMark"> — </span>A chest radiograph is not required for the diagnosis of Ebstein anomaly but is a common component of the evaluation [<a href="#rid22">22</a>]. The chest radiograph results vary depending upon the severity of the disease [<a href="#rid24">24</a>]. In severe cases, the chest radiograph reveals massive cardiomegaly (often termed a "wall-to-wall" heart) with a small ascending aorta and normal or diminished pulmonary vascularity  (<a class="graphic graphic_diagnosticimage graphicRef103912" href="/d/graphic/103912.html" rel="external">image 2</a>). The right atrium is prominent and makes up the right heart border; the left heart border becomes straight or convex due to dilated and displaced right ventricular outflow. The chest radiograph may be normal in patients with mild disease.</p><p class="headingAnchor" id="H9"><span class="h1">DIAGNOSIS AND EVALUATION</span></p><p class="headingAnchor" id="H2385522417"><span class="h2">When to suspect Ebstein anomaly</span><span class="headingEndMark"> — </span>Ebstein anomaly should be suspected in cyanotic infants, children, and adults, and in individuals with tricuspid regurgitation with or without heart failure and in those presenting with paradoxical systemic embolism or arrhythmias. Ebstein anomaly also may be detected as an incidental finding on an echocardiogram performed for unrelated reasons, including in asymptomatic individuals.</p><p class="headingAnchor" id="H2612767331"><span class="h2">How to diagnose Ebstein anomaly</span><span class="headingEndMark"> — </span>The diagnosis of Ebstein anomaly may be suspected clinically, but is confirmed by identification of apical displacement of the attachment of the septal tricuspid valve leaflet by ≥8 mm/m<sup>2</sup> indexed by body surface area compared with the attachment of the anterior mitral valve leaflet. This is most commonly demonstrated in the apical four-chamber transthoracic echocardiographic view  (<a class="graphic graphic_figure graphicRef103702" href="/d/graphic/103702.html" rel="external">figure 1</a> and <a class="graphic graphic_diagnosticimage graphicRef103911" href="/d/graphic/103911.html" rel="external">image 1</a> and <a class="graphic graphic_movie graphicRef58746" href="/d/graphic/58746.html" rel="external">movie 1</a>). This finding may also be appreciated by other imaging techniques, such as CMR.</p><p>Other features commonly associated with Ebstein anomaly are described below. (See <a class="local">'Key features'</a> below.)</p><p class="headingAnchor" id="H2346668903"><span class="h2">Approach to diagnosis and evaluation</span><span class="headingEndMark"> — </span>We recommend the following approach for diagnosis and evaluation of Ebstein anomaly. Further details of individual tests are discussed below.</p><p class="bulletIndent1"><span class="glyph">●</span>Initial imaging</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Transthoracic echocardiography is generally the key test for diagnosis, initial anatomic evaluation, and follow-up of Ebstein anomaly [<a href="#rid25">25,26</a>]. (See <a class="local">'Echocardiography'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We recommend CMR imaging for patients with nondiagnostic echocardiography as well as in patients undergoing surgical tricuspid valve intervention. CMR provides information complementary to that obtained from echocardiography, including quantification of right ventricular size and function in addition to visualization of tricuspid valve anatomy and additional structural abnormalities [<a href="#rid25">25-28</a>]. (See <a class="local">'Cardiovascular magnetic resonance'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Additional tests to evaluate patients with Ebstein anomaly:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We recommend routine formal exercise testing with oximetry to assess exercise capacity, heart rate and blood pressure response to exercise, potential desaturation with exercise, and exercise-induced arrhythmias. Cardiopulmonary exercise testing with measurement of oxygen consumption is helpful in assessing functional limitation (eg, when cardiomegaly is present with few or no symptoms). (See <a class="local">'Exercise testing'</a> below and  <a class="medical medical_review" href="/d/html/3465.html" rel="external">"Cardiopulmonary exercise testing in cardiovascular disease"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We suggest the following routine arrhythmia assessment in patients with Ebstein anomaly: an ECG, ECG monitoring during exercise, and annual 24-hour continuous ambulatory ECG (Holter) monitoring or use of another prolonged heart rhythm monitoring device. For patients with tachyarrhythmias, evidence of pre-excitation on ECG, or planned operation for Ebstein anomaly, we suggest a consultation with a congenital heart rhythm specialist for further evaluation, which may include an electrophysiologic study (EPS). (See <a class="local">'Arrhythmia evaluation'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cardiac catheterization with hemodynamic assessment is recommended for patients with suspected pulmonary artery hypertension or discordant clinical and noninvasive testing, and for patients who are being evaluated for possible patent foramen ovale (PFO) or atrial septal defect (ASD) device closure or bidirectional cavopulmonary anastomosis. (See <a class="local">'Cardiac catheterization'</a> below.)</p><p></p><p class="headingAnchor" id="H590289626"><span class="h2">Key imaging tests</span></p><p class="headingAnchor" id="H12"><span class="h3">Echocardiography</span></p><p class="headingAnchor" id="H2678144182"><span class="h4">Key features</span><span class="headingEndMark"> — </span>Comprehensive transthoracic two-dimensional and Doppler echocardiography is the most useful tool for establishing a diagnosis of Ebstein anomaly  (<a class="graphic graphic_movie graphicRef58746" href="/d/graphic/58746.html" rel="external">movie 1</a> and <a class="graphic graphic_diagnosticimage graphicRef103911" href="/d/graphic/103911.html" rel="external">image 1</a>) [<a href="#rid25">25,26</a>]. The transthoracic echocardiogram generally confirms the diagnosis, determines the severity of the disease, and defines potential associated cardiac defects. The four-chamber view is particularly helpful, as it demonstrates the degree of mobility of the anterior leaflet, the displacement of the septal leaflet, and an impression of the severity of the tricuspid regurgitation. All echocardiographic views are important to delineate the severity of the tricuspid valve regurgitation, which may be incompletely visualized using the standard four-chamber view. Three-dimensional echocardiography is being used with increasing frequency to supplement standard two-dimensional images for analysis of tricuspid valve anatomy and for assessment of right ventricular size and function [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/d/html/5292.html" rel="external">"Echocardiographic evaluation of the tricuspid valve"</a>.)</p><p>The following are the most important echocardiographic findings [<a href="#rid29">29,30</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The key diagnostic finding for Ebstein anomaly is the apical displacement of the septal tricuspid valve leaflet indexed to the body surface area (by ≥8 mm/m<sup>2</sup> [compared with the position of the anterior mitral valve leaflet]) demonstrated in the apical four-chamber view. The degree of displacement affects the severity of clinical manifestations.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abnormalities of the tricuspid valve and right heart of varying severity are seen among patients with Ebstein anomaly:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Degree of failure of delamination of each of the three leaflets. (See <a class="local">'Tricuspid valve'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Tricuspid regurgitation – This is usually low velocity (since pulmonary pressures are normal) with an origin at the most apically or anteriorly displaced point of the valve. The jet may be missed due to its laminar nature or due to unusual direction, such as inferiorly in a valve that is displaced into the right ventricular outflow tract. Occasionally, tricuspid regurgitation can be best assessed in parasternal right ventricular inflow views and modified parasternal short-axis views.</p><p></p><p class="bulletIndent2">Formal quantification of tricuspid valve regurgitation is challenging in patients with Ebstein anomaly. In non-Ebstein adults, the criteria for severe tricuspid regurgitation include a vena contracta width &gt;0.7 cm and systolic flow reversal in the hepatic veins [<a href="#rid31">31,32</a>]. However, these features are often not present in Ebstein anomaly patients of any age due to the large compliant right atrium and atrialized right ventricle [<a href="#rid33">33</a>]. A significant leaflet coaptation gap on 2D echo associated with a large regurgitant jet on color Doppler is the best indicator of severe regurgitation in Ebstein anomaly [<a href="#rid25">25,26</a>]. (See  <a class="medical medical_review" href="/d/html/8119.html" rel="external">"Etiology, clinical features, and evaluation of tricuspid regurgitation", section on 'Echocardiography'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An increase in right heart volume, caused by an enlarged atrialized portion of the right ventricle and volume overload of the functional right ventricle. (See <a class="local">'Right ventricle'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Concurrent congenital lesions are commonly seen (see <a class="local">'Associated cardiovascular defects'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>ASD or PFO, often with associated bidirectional shunting. In patients with suboptimal echocardiographic image quality, saline-contrast echocardiography provides a sensitive test to detect right-to-left intracardiac shunting.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Left-sided cardiac lesions (left ventricular systolic and diastolic dysfunction, mitral valve prolapse, bicuspid aortic valve, small left ventricle).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>L-transposition of the great arteries. (See  <a class="medical medical_review" href="/d/html/83229.html" rel="external">"L-transposition of the great arteries (L-TGA): Anatomy, clinical features, and diagnosis"</a>.)</p><p></p><p>A transesophageal echocardiogram may provide additional information when the transthoracic echocardiographic images are not technically sufficient to identify the structural and functional abnormalities [<a href="#rid22">22</a>].</p><p>Intrauterine diagnosis of Ebstein anomaly can be made by fetal echocardiography [<a href="#rid34">34</a>].</p><p class="headingAnchor" id="H3701330657"><span class="h4">GOSE score (Celermajer index)</span><span class="headingEndMark"> — </span>The Great Ormond Street Score (GOSE) is commonly used for echocardiographic evaluation of the neonate. This score is defined as the ratio of the area of the right atrium and atrialized right ventricle to the combined area of the functional right ventricle, left atrium, and left ventricle; the greater the ratio, the worse the prognosis [<a href="#rid35">35-37</a>].</p><p class="headingAnchor" id="H4097562332"><span class="h3">Cardiovascular magnetic resonance</span><span class="headingEndMark"> — </span>Since information obtained from CMR is complementary to that obtained from echocardiography, combined CMR and echocardiographic imaging are usually performed prior to and following surgical tricuspid valve intervention [<a href="#rid25">25-28</a>]. We generally suggest pre- and postoperative CMR for all patients with Ebstein anomaly who do not require general anesthesia for the scan and for selected patients who do require general anesthesia for scanning [<a href="#rid24">24</a>]. CMR imaging primarily enables quantification of right ventricular size and function. Visualization of tricuspid valve anatomy is also possible  (<a class="graphic graphic_diagnosticimage graphicRef109940" href="/d/graphic/109940.html" rel="external">image 3</a>) [<a href="#rid38">38-40</a>]. Given the unusual tricuspid valve and right ventricular morphology and lack of standardized CMR imaging protocols, variability of calculated right ventricular volumes may be noted when Ebstein patients are compared with patients with other congenital heart defects; in addition, there may be variability of volumetric measurements between different centers [<a href="#rid25">25,26,28,41</a>]. Furthermore, the right ventricular ejection fraction may overestimate true right ventricular contractility in the setting of severe tricuspid regurgitation. Prediction of right ventricular function after tricuspid valve repair or replacement remains difficult. Right ventricular function is generally depressed immediately after tricuspid valve repair or replacement and may or may not recover over time with right ventricular remodeling.</p><p class="headingAnchor" id="H61224182"><span class="h2">Additional tests</span><span class="headingEndMark"> — </span>The following additional tests are generally performed to evaluate patients diagnosed with Ebstein anomaly.</p><p class="headingAnchor" id="H1589510179"><span class="h3">Exercise testing</span><span class="headingEndMark"> — </span>For patients with Ebstein anomaly, we perform formal exercise testing with oximetry or cardiopulmonary exercise testing to assess exercise capacity, heart rate and blood pressure response to exercise, potential desaturation with exercise, and exercise-induced arrhythmias. Pulse oximetry at rest and during exercise in patients with Ebstein anomaly aids in risk stratification [<a href="#rid22">22</a>]. The resting oxygen saturation is a major predictor of exercise tolerance and oxygen saturation at peak exercise [<a href="#rid42">42</a>].</p><p>For patients with Ebstein anomaly who have cardiomegaly with few or no symptoms, cardiopulmonary exercise testing with measurement of oxygen consumption is helpful in assessing functional limitations. (See  <a class="medical medical_review" href="/d/html/3465.html" rel="external">"Cardiopulmonary exercise testing in cardiovascular disease"</a>.)</p><p class="headingAnchor" id="H990673697"><span class="h3">Arrhythmia evaluation</span><span class="headingEndMark"> — </span>For arrhythmia assessment, we suggest an ECG and annual continuous 24-hour ambulatory ECG (Holter) monitoring or monitoring with another prolonged ambulatory monitoring device, as well as ECG monitoring during exercise. For patients with tachyarrhythmias, evidence of pre-excitation on ECG, or planned operation for Ebstein anomaly, consultation with a congenital heart rhythm specialist is suggested. As noted above, the ECG may reveal evidence of arrhythmias or preexcitation. We generally suggest annual 24-hour ambulatory (Holter) monitoring or monitoring with another prolonged ambulatory monitoring device as a means of identifying arrhythmias.</p><p>Among patients referred to a congenital heart rhythm specialist, further evaluation may include EPS. The role of EPS for the identification of accessory pathways and radiofrequency catheter ablation is discussed separately. EPS may also help exclude the presence of ventricular arrhythmias. In our practice, we perform EPS in many adult Ebstein patients prior to operation to detect concealed pathways, guide the extent of intraoperative Maze or cryoablation procedures, and determine the risk of ventricular arrhythmias. In children, preoperative EPS is generally limited to those with Wolff-Parkinson-White syndrome or known/suspected arrhythmia [<a href="#rid43">43</a>]. (See  <a class="medical medical_review" href="/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis", section on 'Evaluation'</a>.)</p><p class="headingAnchor" id="H2761781043"><span class="h3">Cardiac catheterization</span><span class="headingEndMark"> — </span>Cardiac catheterization with hemodynamic assessment is recommended for patients with suspected pulmonary artery hypertension, discordant clinical and noninvasive testing, and for patients who are being evaluated for possible PFO or ASD device closure or bidirectional cavopulmonary anastomosis. Information concerning pulmonary artery pressures and left ventricular end-diastolic pressure is particularly important if a bidirectional cavopulmonary shunt is being considered [<a href="#rid24">24</a>]. Cardiac catheterization with hemodynamic assessment is also recommended for patients with advanced features of Ebstein anomaly and biventricular dysfunction to help guide the choice between conventional surgical intervention or cardiac transplantation.</p><p>Comprehensive hemodynamic cardiac catheterization is required prior to potential device closure, as PFO or ASD closure may further increase right atrial filling pressures at rest or during exercise and can lead to hemodynamic decompensation. In selected cases, assessment of cardiac hemodynamics during exercise with and without balloon-occlusion of the interatrial septal defect may be helpful for decision making. Since isolated ASD catheter-based or surgical closure may result in hemodynamic decompensation, surgical repair of Ebstein anomaly combined with ASD closure is generally preferred over isolated device ASD closure. (See  <a class="medical medical_review" href="/d/html/108790.html" rel="external">"Ebstein anomaly: Management and prognosis"</a>.)</p><p>Coronary angiography or coronary computed tomographic angiography is suggested when surgical repair is planned in patients with suspected coronary artery disease or risk factors for coronary disease, including men ≥35 years old, premenopausal women ≥35 years with coronary risk factors, and postmenopausal women [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H3498825385"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Ebstein anomaly should be distinguished (generally by echocardiography and other clinical features) from other causes of tricuspid regurgitation and right-sided chamber enlargement including the following conditions. A key distinction is that other conditions are associated with a septal leaflet displacement index of less than 8 mm/m<sup>2</sup> body surface area. (See  <a class="medical medical_review" href="/d/html/8119.html" rel="external">"Etiology, clinical features, and evaluation of tricuspid regurgitation"</a> and  <a class="medical medical_review" href="/d/html/4931.html" rel="external">"Arrhythmogenic right ventricular cardiomyopathy: Anatomy, histology, and clinical manifestations"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Uhl anomaly, which is characterized by right ventricular dilation with thin, hypokinetic right ventricular myocardium. (See  <a class="medical medical_review" href="/d/html/4931.html" rel="external">"Arrhythmogenic right ventricular cardiomyopathy: Anatomy, histology, and clinical manifestations", section on 'Uhl anomaly'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Congenital tricuspid valve dysplasia, which is characterized by malformed valve leaflets with no excessive displacement or tethering of tricuspid valve leaflets to the right ventricular myocardium.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tricuspid valve prolapse, which is manifest as tricuspid valve leaflet prolapse without excessive displacement or tethering of the leaflets to the right ventricular myocardium.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tricuspid valve vegetations due to infectious or noninfectious endocarditis, which is characterized by the presence of vegetations with no tethering or displacement of tricuspid valve leaflets into the right ventricular myocardium.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Carcinoid heart disease in which valve leaflets are thickened and retracted resulting in tricuspid valve regurgitation. (See  <a class="medical medical_review" href="/d/html/8135.html" rel="external">"Carcinoid heart disease", section on 'Diagnosis and evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Traumatic injury of the tricuspid valve or ruptured tricuspid valve chordae, which is suggested by a history of cardiac instrumentation (eg, right ventricular endomyocardial biopsy, electrophysiologic study) or chest trauma and features of one or more flail leaflets.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Arrhythmogenic right ventricular cardiomyopathy with a morphologically normal tricuspid valve with annular dilation, right ventricular dilation, and dysfunction. (See  <a class="medical medical_review" href="/d/html/4931.html" rel="external">"Arrhythmogenic right ventricular cardiomyopathy: Anatomy, histology, and clinical manifestations"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic enlargement of the right atrium, a rare disorder that may be associated with tricuspid regurgitation [<a href="#rid44">44</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Functional tricuspid regurgitation caused by annular dilatation or impaired right ventricular geometry of various causes.</p><p></p><p>Ebstein anomaly should also be distinguished from other causes of cyanosis, which are usually also diagnosed by echocardiography. In Ebstein anomaly, the right heart is frequently enlarged but pulmonary artery hypertension is less common, in contrast to cyanotic congenital heart disease associated with Eisenmenger syndrome. The evaluation of cyanosis in infants and children is discussed separately. (See  <a class="medical medical_review" href="/d/html/1423.html" rel="external">"Medical management of cyanotic congenital heart disease in adults"</a> and  <a class="medical medical_review" href="/d/html/14305.html" rel="external">"Approach to cyanosis in the newborn"</a> and  <a class="medical medical_review" href="/d/html/6437.html" rel="external">"Approach to cyanosis in children"</a>.)</p><p class="headingAnchor" id="H3547159053"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112260.html" rel="external">"Society guideline links: Arrhythmias in adults"</a> and  <a class="medical medical_society_guidelines" href="/d/html/115482.html" rel="external">"Society guideline links: Cardiac valve disease"</a> and  <a class="medical medical_society_guidelines" href="/d/html/122280.html" rel="external">"Society guideline links: Congenital heart disease in adults"</a>.)</p><p class="headingAnchor" id="H10180269"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Ebstein anomaly is a congenital malformation characterized by variably malformed and displaced tricuspid valve leaflets that are partly attached to the tricuspid valve annulus and partly attached to the right ventricular endocardium. These features cause tricuspid valve regurgitation and right heart enlargement. (See <a class="local">'Morphology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac defects associated with Ebstein anomaly include atrial septal defect/patent foramen ovale, one or more accessory conduction pathways, ventricular septal defect, pulmonary outflow obstruction, patent ductus arteriosus, mitral valve prolapse, bicuspid aortic valve, and left ventricular noncompaction. (See <a class="local">'Associated cardiovascular defects'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The clinical presentation varies with the severity of the lesion. Severe malformations are associated with fetal hydrops, cyanosis in neonates, and heart failure in infants. Milder disease may be detected as an incidental murmur in children or adults; these patients may remain asymptomatic for decades. Adolescents and adults commonly present with atrial arrhythmias, often associated with one or more accessory pathways. (See <a class="local">'Clinical manifestations'</a> above and  <a class="medical medical_review" href="/d/html/108790.html" rel="external">"Ebstein anomaly: Management and prognosis", section on 'Prognosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of Ebstein anomaly is made by identification of apical displacement of the attachment of the septal tricuspid valve leaflet indexed by body surface area by ≥8 mm/m<sup>2</sup> compared with the attachment of the anterior mitral valve leaflet, demonstrated in the apical four-chamber transthoracic echocardiographic view  (<a class="graphic graphic_figure graphicRef103702" href="/d/graphic/103702.html" rel="external">figure 1</a> and <a class="graphic graphic_diagnosticimage graphicRef103911" href="/d/graphic/103911.html" rel="external">image 1</a>) This finding may also be appreciated by other imaging techniques. (See <a class="local">'How to diagnose Ebstein anomaly'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Echocardiography is generally the key test for diagnosis and initial anatomic evaluation of Ebstein anomaly. We recommend cardiovascular magnetic resonance (CMR) imaging for patients with nondiagnostic echocardiography, as well as in patients undergoing surgical tricuspid valve intervention. CMR provides information complementary to that obtained from echocardiography, including quantification of right ventricular size and function. (See <a class="local">'Approach to diagnosis and evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diagnostic features of Ebstein anomaly include apical displacement of the septal tricuspid leaflet compared with the position of the anterior mitral valve leaflet (by ≥8 mm/m<sup>2</sup> body surface area), multiple fibrous attachments of tricuspid valve leaflets to the underlying RV myocardium, enlarged right heart volume, and low velocity tricuspid regurgitation. (See <a class="local">'Key features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation of the patient with Ebstein anomaly includes exercise testing with oximetry, as well as arrhythmia evaluation, which in some cases includes electrophysiologic study. Additional testing such as cardiopulmonary exercise testing, cardiac catheterization, and coronary angiography are indicated in only selected patients. (See <a class="local">'Diagnosis and evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The differential diagnosis of Ebstein anomaly includes other causes of tricuspid regurgitation or right-sided chamber enlargement and other causes of cyanosis. A key distinction is that other conditions are associated with a septal leaflet displacement index of less than 8 mm/m<sup>2</sup> body surface area. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="headingAnchor" id="H193432422"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff thank Brojendra N Agarwala, MD, and Ziyad M Hijazi, MD, MPH, FAAP, FACC, MSCAI, FAHA, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lupo PJ, Langlois PH, Mitchell LE. Epidemiology of Ebstein anomaly: prevalence and patterns in Texas, 1999-2005. Am J Med Genet A 2011; 155A:1007.</a></li><li><a class="nounderline abstract_t">Correa-Villaseñor A, Ferencz C, Neill CA, et al. Ebstein's malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infant Study Group. Teratology 1994; 50:137.</a></li><li><a class="nounderline abstract_t">Pradat P, Francannet C, Harris JA, Robert E. The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations. Pediatr Cardiol 2003; 24:195.</a></li><li><a class="nounderline abstract_t">Eckerström F, Dellborg M, Hjortdal VE, et al. Mortality in Patients With Ebstein Anomaly. J Am Coll Cardiol 2023; 81:2420.</a></li><li><a class="nounderline abstract_t">Benson DW, Silberbach GM, Kavanaugh-McHugh A, et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 1999; 104:1567.</a></li><li><a class="nounderline abstract_t">Kelle AM, Bentley SJ, Rohena LO, et al. Ebstein anomaly, left ventricular non-compaction, and early onset heart failure associated with a de novo α-tropomyosin gene mutation. Am J Med Genet A 2016; 170:2186.</a></li><li><a class="nounderline abstract_t">Postma AV, van Engelen K, van de Meerakker J, et al. Mutations in the sarcomere gene MYH7 in Ebstein anomaly. Circ Cardiovasc Genet 2011; 4:43.</a></li><li><a class="nounderline abstract_t">van Engelen K, Postma AV, van de Meerakker JB, et al. Ebstein's anomaly may be caused by mutations in the sarcomere protein gene MYH7. Neth Heart J 2013; 21:113.</a></li><li><a class="nounderline abstract_t">Yalonetsky S, Tobler D, Greutmann M, et al. Cardiac magnetic resonance imaging and the assessment of ebstein anomaly in adults. Am J Cardiol 2011; 107:767.</a></li><li><a class="nounderline abstract_t">BURCHELL HB, DUSHANE JW, KILBY RA, WOOD EH. Ebstein's malformation: a clinical and laboratory study. Medicine (Baltimore) 1956; 35:161.</a></li><li><a class="nounderline abstract_t">Attenhofer Jost CH, Connolly HM, O'Leary PW, et al. Left heart lesions in patients with Ebstein anomaly. Mayo Clin Proc 2005; 80:361.</a></li><li><a class="nounderline abstract_t">Watson H. Electrode catheters and the diagnosis of Ebstein's anomaly of the tricuspid valve. Br Heart J 1966; 28:161.</a></li><li><a class="nounderline abstract_t">SUMNER RG, JACOBY WJ Jr, TUCKER DH. EBSTEIN'S ANOMALY ASSOCIATED WITH CARDIOMYOPATHY AND PULMONARY HYPERTENSION. Circulation 1964; 30:578.</a></li><li><a class="nounderline abstract_t">Attenhofer Jost CH, Connolly HM, Dearani JA, et al. Ebstein's anomaly. Circulation 2007; 115:277.</a></li><li><a class="nounderline abstract_t">Celermajer DS, Bull C, Till JA, et al. Ebstein's anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol 1994; 23:170.</a></li><li><a class="nounderline abstract_t">Seward JB, Tajik AJ, Feist DJ, Smith HC. Ebstein's anomaly in an 85-year-old man. Mayo Clin Proc 1979; 54:193.</a></li><li><a class="nounderline abstract_t">Watson H. Natural history of Ebstein's anomaly of tricuspid valve in childhood and adolescence. An international co-operative study of 505 cases. Br Heart J 1974; 36:417.</a></li><li><a class="nounderline abstract_t">LEV M, GIBSON S, MILLER RA. Ebstein's disease with Wolff-Parkinson-White syndrome; report of a case with a histopathologic study of possible conduction pathways. Am Heart J 1955; 49:724.</a></li><li><a class="nounderline abstract_t">Cappato R, Schlüter M, Weiss C, et al. Radiofrequency current catheter ablation of accessory atrioventricular pathways in Ebstein's anomaly. Circulation 1996; 94:376.</a></li><li><a class="nounderline abstract_t">Attenhofer Jost CH, Connolly HM, Scott CG, et al. Increased risk of possible paradoxical embolic events in adults with ebstein anomaly and severe tricuspid regurgitation. Congenit Heart Dis 2014; 9:30.</a></li><li><a class="nounderline abstract_t">Fontana ME, Wooley CF. Sail sound in Ebstein's anomaly of the tricuspid valve. Circulation 1972; 46:155.</a></li><li><a class="nounderline abstract_t">Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 2008; 118:e714.</a></li><li><a class="nounderline abstract_t">VAN LINGEN B, BAUERSFELD SR. The electrocardiogram in Ebstein's anomaly of the tricuspid valve. Am Heart J 1955; 50:13.</a></li><li><a class="nounderline abstract_t">Dearani JA, Mora BN, Nelson TJ, et al. Ebstein anomaly review: what's now, what's next? Expert Rev Cardiovasc Ther 2015; 13:1101.</a></li><li><a class="nounderline abstract_t">Qureshi MY, O'Leary PW, Connolly HM. Cardiac imaging in Ebstein anomaly. Trends Cardiovasc Med 2018; 28:403.</a></li><li><a class="nounderline abstract_t">Qureshi MY, Sommer RJ, Cabalka AK. Tricuspid Valve Imaging and Intervention in Pediatric and Adult Patients With Congenital Heart Disease. JACC Cardiovasc Imaging 2019; 12:637.</a></li><li><a class="nounderline abstract_t">Yang D, Li X, Sun JY, et al. Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly. J Cardiovasc Magn Reson 2018; 20:69.</a></li><li><a class="nounderline abstract_t">Neijenhuis RML, Tsang VT, Marek J, et al. Cone reconstruction for Ebstein anomaly: Late biventricular function and possible remodeling. J Thorac Cardiovasc Surg 2021; 161:1097.</a></li><li><a class="nounderline abstract_t">Shiina A, Seward JB, Edwards WD, et al. Two-dimensional echocardiographic spectrum of Ebstein's anomaly: detailed anatomic assessment. J Am Coll Cardiol 1984; 3:356.</a></li><li><a class="nounderline abstract_t">Gussenhoven EJ, Stewart PA, Becker AE, et al. "Offsetting" of the septal tricuspid leaflet in normal hearts and in hearts with Ebstein's anomaly. Anatomic and echographic correlation. Am J Cardiol 1984; 54:172.</a></li><li><a class="nounderline abstract_t">Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.</a></li><li><a class="nounderline abstract_t">Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16:777.</a></li><li><a class="nounderline abstract_t">Graham TP Jr, Driscoll DJ, Gersony WM, et al. Task Force 2: congenital heart disease. J Am Coll Cardiol 2005; 45:1326.</a></li><li><a class="nounderline abstract_t">Freud LR, Escobar-Diaz MC, Kalish BT, et al. Outcomes and Predictors of Perinatal Mortality in Fetuses With Ebstein Anomaly or Tricuspid Valve Dysplasia in the Current Era: A Multicenter Study. Circulation 2015; 132:481.</a></li><li><a class="nounderline abstract_t">Knott-Craig CJ, Goldberg SP, Overholt ED, et al. Repair of neonates and young infants with Ebstein's anomaly and related disorders. Ann Thorac Surg 2007; 84:587.</a></li><li><a class="nounderline abstract_t">Knott-Craig CJ, Goldberg SP, Kirklin JK. Surgical strategy to prevent cardiac injury during reoperation in infants. J Cardiothorac Surg 2008; 3:10.</a></li><li><a class="nounderline abstract_t">Celermajer DS, Cullen S, Sullivan ID, et al. Outcome in neonates with Ebstein's anomaly. J Am Coll Cardiol 1992; 19:1041.</a></li><li><a class="nounderline abstract_t">Attenhofer Jost CH, Edmister WD, Julsrud PR, et al. Prospective comparison of echocardiography versus cardiac magnetic resonance imaging in patients with Ebstein's anomaly. Int J Cardiovasc Imaging 2012; 28:1147.</a></li><li><a class="nounderline abstract_t">Kilner PJ, Geva T, Kaemmerer H, et al. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. Eur Heart J 2010; 31:794.</a></li><li><a class="nounderline abstract_t">Cawley PJ, Maki JH, Otto CM. Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation 2009; 119:468.</a></li><li><a class="nounderline abstract_t">Alfakih K, Plein S, Bloomer T, et al. Comparison of right ventricular volume measurements between axial and short axis orientation using steady-state free precession magnetic resonance imaging. J Magn Reson Imaging 2003; 18:25.</a></li><li><a class="nounderline abstract_t">MacLellan-Tobert SG, Driscoll DJ, Mottram CD, et al. Exercise tolerance in patients with Ebstein's anomaly. J Am Coll Cardiol 1997; 29:1615.</a></li><li><a class="nounderline abstract_t">Wackel P, Cannon B, Dearani J, et al. Arrhythmia after cone repair for Ebstein anomaly: The Mayo Clinic experience in 143 young patients. Congenit Heart Dis 2018; 13:26.</a></li><li><a class="nounderline abstract_t">Zhang J, Zhang L, He L, et al. Clinical Presentation, Diagnosis, and Management of Idiopathic Enlargement of the Right Atrium: An Analysis Based on Systematic Review of 153 Reported Cases. Cardiology 2021; 146:88.</a></li></ol></div><div id="topicVersionRevision">Topic 8146 Version 40.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21465650" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Epidemiology of Ebstein anomaly: prevalence and patterns in Texas, 1999-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7801301" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Ebstein's malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infant Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12632215" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37344044" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Mortality in Patients With Ebstein Anomaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10587520" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27177193" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Ebstein anomaly, left ventricular non-compaction, and early onset heart failure associated with a de novoα-tropomyosin gene mutation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21127202" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Mutations in the sarcomere gene MYH7 in Ebstein anomaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21604106" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Ebstein's anomaly may be caused by mutations in the sarcomere protein gene MYH7.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21247528" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Cardiac magnetic resonance imaging and the assessment of ebstein anomaly in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13368963" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Ebstein's malformation: a clinical and laboratory study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15757018" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Left heart lesions in patients with Ebstein anomaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4952877" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Electrode catheters and the diagnosis of Ebstein's anomaly of the tricuspid valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14211820" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : EBSTEIN'S ANOMALY ASSOCIATED WITH CARDIOMYOPATHY AND PULMONARY HYPERTENSION.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17228014" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Ebstein's anomaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8277076" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Ebstein's anomaly: presentation and outcome from fetus to adult.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/431126" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Ebstein's anomaly in an 85-year-old man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4134860" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Natural history of Ebstein's anomaly of tricuspid valve in childhood and adolescence. An international co-operative study of 505 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14376326" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Ebstein's disease with Wolff-Parkinson-White syndrome; report of a case with a histopathologic study of possible conduction pathways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8759079" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Radiofrequency current catheter ablation of accessory atrioventricular pathways in Ebstein's anomaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23601093" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Increased risk of possible paradoxical embolic events in adults with ebstein anomaly and severe tricuspid regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5039818" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Sail sound in Ebstein's anomaly of the tricuspid valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18997169" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14387934" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The electrocardiogram in Ebstein's anomaly of the tricuspid valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26357983" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Ebstein anomaly review: what's now, what's next?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29409687" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Cardiac imaging in Ebstein anomaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30947906" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Tricuspid Valve Imaging and Intervention in Pediatric and Adult Patients With Congenital Heart Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30257686" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33293067" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Cone reconstruction for Ebstein anomaly: Late biventricular function and possible remodeling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6693624" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Two-dimensional echocardiographic spectrum of Ebstein's anomaly: detailed anatomic assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6741810" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : "Offsetting" of the septal tricuspid leaflet in normal hearts and in hearts with Ebstein's anomaly. Anatomic and echographic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18820172" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12835667" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15837282" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Task Force 2: congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26059011" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Outcomes and Predictors of Perinatal Mortality in Fetuses With Ebstein Anomaly or Tricuspid Valve Dysplasia in the Current Era: A Multicenter Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17643640" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Repair of neonates and young infants with Ebstein's anomaly and related disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18307805" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Surgical strategy to prevent cardiac injury during reoperation in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1552092" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Outcome in neonates with Ebstein's anomaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21822629" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Prospective comparison of echocardiography versus cardiac magnetic resonance imaging in patients with Ebstein's anomaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20067914" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19171869" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12815636" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Comparison of right ventricular volume measurements between axial and short axis orientation using steady-state free precession magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9180127" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Exercise tolerance in patients with Ebstein's anomaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29316261" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Arrhythmia after cone repair for Ebstein anomaly: The Mayo Clinic experience in 143 young patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33242857" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Clinical Presentation, Diagnosis, and Management of Idiopathic Enlargement of the Right Atrium: An Analysis Based on Systematic Review of 153 Reported Cases.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
